| Rosuvastatin |
№ II-14196/ 28.07.2011 |
ROSWERA, Film coated tablet, 30, mg, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
19.77 |
3.95 |
23.72 |
6% |
1.19 |
20.96 |
4.19 |
25.15 |
18% |
3.56 |
24.52 |
4.9 |
29.42 |
|
НСР-2177/20.12.2013 |
28.01.2014 |
28.01.2014 |
Неактивен |
2406 |
| Rosuvastatin |
II-14195/ 28.07.2011 |
ROSWERA, Film coated tablet, 20, mg, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
12.2 |
2.44 |
14.64 |
6% |
0.73 |
12.93 |
2.59 |
15.52 |
18% |
2.2 |
15.13 |
3.03 |
18.16 |
|
НСР-1671/11.11.2013 |
26.11.2013 |
26.11.2013 |
Неактивен |
2262 |
| Rosuvastatin |
II-14195/ 28.07.2011 |
ROSWERA, Film coated tablet, 20, mg, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
14.28 |
2.86 |
17.14 |
6% |
0.86 |
15.14 |
3.03 |
18.17 |
18% |
2.57 |
17.71 |
3.54 |
21.25 |
|
КЦРР-1827/12.12.2012 г |
05.02.2013 |
05.02.2013 |
Неактивен |
2262 |
| Rosuvastatin |
II-14193/ 28.07.2011 |
ROSWERA, Film coated tablet, 10, mg, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
6.81 |
1.36 |
8.17 |
7% |
0.48 |
7.29 |
1.46 |
8.75 |
20% |
1.36 |
8.65 |
1.73 |
10.38 |
|
КЦРР-1827/12.12.2012 г |
05.02.2013 |
05.02.2013 |
Неактивен |
2261 |
| Rosuvastatin |
II-14193/ 28.07.2011 |
ROSWERA, Film coated tablet, 10, mg, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
13.06 |
2.61 |
15.67 |
6% |
0.78 |
13.84 |
2.77 |
16.61 |
18% |
2.35 |
16.19 |
3.24 |
19.43 |
|
КЦ-2789/03.10.2011 |
18.10.2011 |
18.10.2011 |
Неактивен |
2261 |
| Rosuvastatin |
II-14195/ 28.07.2011 |
ROSWERA, Film coated tablet, 20, mg, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
24.74 |
4.95 |
29.69 |
6% |
1.48 |
26.22 |
5.24 |
31.46 |
18% |
4.45 |
30.67 |
6.13 |
36.8 |
|
КЦ-2789/03.10.2011 |
18.10.2011 |
18.10.2011 |
Неактивен |
2262 |
| Rosuvastatin |
№ II-14196/ 28.07.2011 |
ROSWERA, Film coated tablet, 30, mg, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
32.76 |
6.55 |
39.31 |
4% |
1.31 |
34.07 |
6.81 |
40.88 |
16% |
5.24 |
39.31 |
7.86 |
47.17 |
|
КЦ-2783/03.10.2011 |
18.10.2011 |
18.10.2011 |
Неактивен |
2406 |
| Rosuvastatin |
№ II-14194/28.07.2011 |
ROSWERA, Film coated tablet, 15, mg, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
19.95 |
3.99 |
23.94 |
6% |
1.2 |
21.15 |
4.23 |
25.38 |
18% |
3.59 |
24.74 |
4.95 |
29.69 |
|
КЦ-2784/03.10.2011 |
18.10.2011 |
18.10.2011 |
Неактивен |
1567 |
| Rota virus, live attenuated |
EU/1/05/330/001 |
Rotarix, Powder and solvent for oral suspension, Human rotavirus RIX4414 strain (live, attenuated) ≥ 106.0 CCID50, mg, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
97.79 |
19.56 |
117.35 |
4% |
3.91 |
101.7 |
20.34 |
122.04 |
16% |
15.65 |
117.35 |
23.47 |
140.82 |
цената се заличава КЦРР-1671/20.11.2012 |
КЦ-262/27.10.2008 |
18.11.2008 |
18.11.2008 |
Заличен |
135 |
| Rota virus, live attenuated |
EU/1/05/330/005 |
ROTARIX, Oral suspension, 1.5 ml, -, Pack: pre-filled oral applicator (glass) |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
81.3 |
16.26 |
97.56 |
4% |
3.25 |
84.55 |
16.91 |
101.46 |
16% |
13.01 |
97.56 |
19.51 |
117.07 |
Протокол №402/24.09.2020 |
НСР-6181/08.05.2015; НСР-13340/28.07.2017; НСР-17029/19.10.2018; НСР-19058/27.06.2019 |
12.07.2019 |
02.10.2020 |
Неактивен |
3932 |
| Rota virus, live attenuated |
EU/1/05/330/005 |
ROTARIX, Oral suspension, 1,5 ml prefilled oral applicator (glass), 1, Pack: dose |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
83.12 |
16.62 |
99.74 |
4% |
3.32 |
86.44 |
17.29 |
103.73 |
16% |
13.3 |
99.74 |
19.95 |
119.69 |
|
НСР-6181/08.05.2015 |
25.05.2015 |
25.05.2015 |
Неактивен |
3932 |
| Rota virus, live attenuated |
EU/1/05/330/009 |
ROTARIX, Oral suspension, 1,5, ml, Pack: 1 squeezable tube (polyethylene) |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals S.A., Белгия |
81.4 |
16.28 |
97.68 |
4% |
3.26 |
84.66 |
16.93 |
101.59 |
16% |
13.02 |
97.68 |
19.54 |
117.22 |
|
НСР-22451/30.09.2020 |
15.10.2020 |
02.11.2020 |
Активен |
17091 |
| Rota virus, live attenuated |
EU/1/05/330/005 |
ROTARIX, Oral suspension, 1.5, ml, Pack: 1 pre-filled oral applicator (glass) |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
81.3 |
16.26 |
97.56 |
4% |
3.25 |
84.55 |
16.91 |
101.46 |
16% |
13.01 |
97.56 |
19.51 |
117.07 |
Протокол №402/24.09.2020 |
НСР-6181/08.05.2015; НСР-13340/28.07.2017; НСР-17029/19.10.2018; НСР-19058/27.06.2019 |
12.07.2019 |
02.11.2020 |
Активен |
3932 |
| Rota virus, live attenuated |
EU/1/05/330/005 |
ROTARIX, Oral suspension, 1.5 ml prefilled oral applicator (glass), -, Pack: 1 dose |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
81.3 |
16.26 |
97.56 |
4% |
3.25 |
84.55 |
16.91 |
101.46 |
16% |
13.01 |
97.56 |
19.51 |
117.07 |
|
НСР-6181/08.05.2015; НСР-13340/28.07.2017; НСР-17029/19.10.2018; НСР-19058/27.06.2019 |
12.07.2019 |
02.08.2019 |
Неактивен |
3932 |
| Rota virus, live attenuated |
EU/1/05/330/005 |
ROTARIX, Oral suspension, 1.5 ml prefilled oral applicator (glass), -, Pack: 1 dose |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
81.6 |
16.32 |
97.92 |
4% |
3.26 |
84.86 |
16.97 |
101.83 |
16% |
13.06 |
97.92 |
19.58 |
117.5 |
|
НСР-6181/08.05.2015; НСР-13340/28.07.2017; НСР-17029/19.10.2018 |
03.11.2018 |
02.12.2018 |
Неактивен |
3932 |
| Rota virus, live attenuated |
EU/1/05/330/005 |
ROTARIX, Oral suspension, 1.5 ml prefilled oral applicator (glass), -, Pack: 1 dose |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
82.14 |
16.43 |
98.57 |
4% |
3.29 |
85.43 |
17.09 |
102.52 |
16% |
13.14 |
98.57 |
19.71 |
118.28 |
|
НСР-6181/08.05.2015; НСР-13340/28.07.2017 |
12.08.2017 |
02.09.2017 |
Неактивен |
3932 |
| Rota virus, live attenuated |
EU/1/05/330/005 |
ROTARIX, Oral suspension, 1,5 ml prefilled oral applicator (glass), -, Pack: 1 dose |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
83.12 |
16.62 |
99.74 |
4% |
3.32 |
86.44 |
17.29 |
103.73 |
16% |
13.3 |
99.74 |
19.95 |
119.69 |
|
НСР-6181/08.05.2015 |
25.05.2015 |
25.05.2015 |
Неактивен |
3932 |
| Rota virus, live attenuated |
EU/1/05/330/005/10.09.08 |
ROTARIX, Oral suspension, 1,5 ml prefilled oral applicator (glass), -, Pack: 1 dose |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
83.12 |
16.62 |
99.74 |
4% |
3.32 |
86.44 |
17.29 |
103.73 |
16% |
13.3 |
99.74 |
19.95 |
119.69 |
|
НСР-6181/08.05.2015 |
25.05.2015 |
25.05.2015 |
Неактивен |
3932 |
| Rota virus, live attenuated |
EU/1/05/330/005/10.09.08 |
ROTARIX, Oral suspension, 1,5 ml prefilled oral applicator (glass), -, Pack: 1 dose |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
84.8 |
16.96 |
101.76 |
4% |
3.39 |
88.19 |
17.64 |
105.83 |
16% |
13.57 |
101.76 |
20.35 |
122.11 |
корекц. Решение НСР-4979/05.11.2014 |
НСР-4593/15.09.2014 |
30.09.2014 |
30.09.2014 |
Неактивен |
3932 |
| Rota virus, live attenuated |
EU/1/05/330/005/10.09.08 |
ROTARIX, Oral suspension, 1,5 ml prefilled oral applicator (glass), -, Pack: 1 dose |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a.Белгия |
94.68 |
18.94 |
113.62 |
4% |
3.79 |
98.47 |
19.69 |
118.16 |
16% |
15.15 |
113.62 |
22.72 |
136.34 |
|
КЦ-2209/17.05.2011 |
01.06.2011 |
01.06.2011 |
Неактивен |
3932 |
| Rota virus, live attenuated |
EU/1/06/348/001 |
RotaTeq, Oral solution, 2 ml, -, Pack: 1 |
MSD VACCINS, Lyon, Франция |
Merck Sharp & Dohme B.V., Холандия |
50.89 |
10.18 |
61.07 |
4% |
2.04 |
52.93 |
10.59 |
63.52 |
16% |
8.14 |
61.07 |
12.21 |
73.28 |
промяна на обстоятелства НСР-12917/08.06.2017 |
НСР-2903/05.03.2014 |
20.03.2014 |
02.07.2017 |
Активен |
2565 |
| Rota virus, live attenuated |
EU/1/06/348/001 |
RotaTeq, Oral solution, 2 ml, -, Pack: 1 |
MSD VACCINS, Lyon, Франция |
Merck Sharp & Dohme B.V., Холандия |
50.89 |
10.18 |
61.07 |
4% |
2.04 |
52.93 |
10.59 |
63.52 |
16% |
8.14 |
61.07 |
12.21 |
73.28 |
промяна на обстоятелства НСР-12917/08.06.2017 |
НСР-2903/05.03.2014 |
20.03.2014 |
02.07.2017 |
Неактивен |
2565 |
| Rota virus, live attenuated |
EU/1/06/348/001 |
RotaTeq, Oral solution, 2 ml, -, Pack: 1 |
Sanofi Pasteur MSD, SNC, Франция |
Merck Sharp & Dohme B.V., Холандия |
50.89 |
10.18 |
61.07 |
4% |
2.04 |
52.93 |
10.59 |
63.52 |
16% |
8.14 |
61.07 |
12.21 |
73.28 |
|
НСР-2903/05.03.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
2565 |
| Edoxaban |
EU/1/16/1152/019 |
Roteas, Film coated tablet, 60, mg, Pack: 30 |
Berlin - Chemie AG, Германия |
Daiichi Sankyo Europe GmbH, Германия |
102.66 |
20.53 |
123.19 |
4% |
4.11 |
106.77 |
21.35 |
128.12 |
16% |
16.43 |
123.2 |
24.64 |
147.84 |
|
НСР-22494/30.09.2020 Предварително изпълнение |
30.09.2020 |
02.10.2020 |
Активен |
17080 |
| Edoxaban |
EU/1/16/1152/006 |
Roteas, Film coated tablet, 30, mg, Pack: 30 |
Berlin - Chemie AG, Германия |
Daiichi Sankyo Europe GmbH, Германия |
102.66 |
20.53 |
123.19 |
4% |
4.11 |
106.77 |
21.35 |
128.12 |
16% |
16.43 |
123.2 |
24.64 |
147.84 |
|
НСР-22494/30.09.2020 Предварително изпълнение |
30.09.2020 |
02.10.2020 |
Активен |
17081 |